LTS Lohmann Therapie-Systeme AG Overview
Pro stress-test →LTS Lohmann Therapie-Systeme is the market leader in transdermal therapeutic systems and oral drug films, serving the global pharmaceutical industry. Founded in 1984, the company specializes in advanced drug delivery systems and pharmaceutical technology.
Strategic Profile
Pro stress-test →LTS focuses on two core technologies—transdermal therapeutic systems (TTS) and oral thin films (OTF)—while expanding into innovative microneedle and active LTS TTS technology. The company operates state-of-the-art GMP-compliant manufacturing facilities in West Caldwell, NJ and Andernach, Germany, positioning it as a critical partner in pharmaceutical development and manufacturing.
Competitive Landscape
Pro stress-test →LTS holds the market leadership position in transdermal therapeutic systems and oral films, competing against smaller specialized manufacturers and in-house pharma development teams. No single dominant competitor dominates the niche; competitive advantage derives from world-class pharmaceutical coating capabilities and GMP-compliant manufacturing at scale.
Industry Context
LTS Lohmann Therapie-Systeme AG operates in Pharmaceutical Drug Delivery Systems.
Key facts
Founded: 1984 · Headquarters: Andernach, Germany · Employees: 1,500 · Revenue: $265M (approximately)